#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fungal infection Pneumonia Partial lipodystrophy Trigeminal neuralgia Polycystic liver disease Parkinson's disease Chronic granulomatous disease Cystic fibrosis gastrointestinal disease Acquired haemophilia Immune-mediated myasthenia gravis Follicle centre lymphoma follicular grade I, II – III Hepatitis D Hodgkin's disease recurrent Anti-glomerular basement membrane disease Pseudoxanthoma elasticum More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent – Treatment Lysosomal storage disorder – Treatment Vascular malformation – Trials in Disease MELAS syndrome – Treatment Angiosarcoma – Life with Disease Behcet’s syndrome – Basic Information Hyperoxaluria – Treatment Encephalitis autoimmune – Diagnostics Systemic sclerosis pulmonary – Life with Disease Metachromatic leukodystrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Febuxostat Hemihydrate Sotrovimab Goserelin Mrna-3210 Maridebart Cafraglutide SONLICROMANOL HYDROCHLORIDE Amlodipine Thiamazole Human Cancellous Bone Alfacalcidol Xanomeline Tartrate IMA401 GSKVX000000030825 Ibutamoren Mesilate Gen1046 Ertapenem Sodium Tusamitamab Ravtansine R3R01 Tofacitinib Citrate Vidofludimus Calcium More therapies…

    Learn about Your Condition

    Right ventricular dysfunction Liver transplant Pterygium Becker's muscular dystrophy Perineal injury Procedural headache Thymic carcinoma Ovarian granulosa cell tumour Peripheral spondyloarthritis Tumour thrombosis Endometrial stromal sarcoma Ewing's sarcoma recurrent Myeloproliferative neoplasm Penile squamous cell carcinoma Migraine without aura More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Neoplasm

  • Study of Spartalizumab and Pazopanib for Patients with Refractory or Recurrent Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Pazopanib
    • Spartalizumab
    France

  • Study on the Safety and Effectiveness of Pembrolizumab, Favezelimab, and Vibostolimab for Children and Young Adults with Blood Cancers or Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    • Neoplasm
    Investigated Drugs:
    • Vibostolimab
    • Favezelimab
    • Pembrolizumab
    Denmark

  • Study on Dostarlimab to Prevent Second Cancer in Patients Cured from Primary Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Dostarlimab
    France

  • A study to evaluate the safety and effectiveness of KD033 in patients with advanced or metastatic solid tumors

    Not recruiting

    1 1 1
    France Spain

  • A Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • GSK4524101A
    • Niraparib Tosilate Monohydrate
    Belgium Czechia Denmark Estonia Greece Italy +2

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma
    • Cervix carcinoma recurrent
    • Endometrial adenocarcinoma
    Investigated Drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9
Previous Page
1 … 12 13 14 15 16 … 25
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!